• Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs
• Products susceptible to illegal marketing: Illegal marketing of biologics and biosimilars
• Clinical Trial Applications for Biologics and Radiopharmaceuticals
• Preparation of the Quality Information for Drug Submissions in the CTD Format: …
• Questions and Answers: Plain Language Labelling Regulations for Prescription Drugs - document